KENNEWICK, Wash., Sept. 25, 2013 (GLOBE NEWSWIRE) — Advanced Medical Isotope Corporation (OTCQB:ADMD), a company engaged in the production and distribution of medical isotopes, has recently signed an agreement with Overton Global Partners to introduce AMIC management to premier institutional fund managers and strategic partners in Europe.
Overton is teaming with AMIC management for a professional and timely European roadshow. The Overton contract is designed to strategically maximize exposure for AMIC with sector specific professional fund managers to drive commitment from supportive investors. Through Overton’s introductions, the potential for forming new, positive business relationships is complemented by establishing the basis for subsequent financing rounds, and close contact with the investors.
AMIC CEO James C. Katzaroff stated, “The professional, boutique Overton team gives AMIC a high potential for establishing strong strategic alliances and financing partners.”
About Advanced Medical Isotope Corporation (AMIC)
AMIC (OTCQB:ADMD) is a U.S.-based public company engaged in the production and distribution of medical isotopes and is developing medical isotope technologies that are changing the practice of medicine and revolutionizing the standard of medical care.
For further information, please review our website at www.isotopeworld.com
The Advanced Medical Isotope Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5139
About Overton Global Partners, LLC.
Overton Global Partners works extensively with small cap companies procuring funding with institutional investors throughout major European financial centers. Overton Global Partners has relations with institutional fund managers in every country within Western Europe, and is developing new relationships in the European emerging countries and in the Middle East. Overton works with small cap companies to raise equity and debt capital from institutional investors located in the major European financial centers.
James C. Katzaroff
Overton Global Partners